Last updated on October 2018

Administration of Kisspeptin in Patients With Hyperprolactinemia


Brief description of study

The goal of this project is to explore the use of exogenous pulsatile kisspeptin as a therapeutic alternative for patients with hyperprolactinemia who are intolerant to current therapies.

Funding Source - FDA OOPD

Clinical Study Identifier: NCT02956447

Contact Investigators or Research Sites near you

Start Over

Isabella McDonald

Massachusetts General Hospital
Boston, MA United States
  Connect »